‌

US Patent 7820206 Modulation of inflammation by hops fractions and derivatives

Patent 7820206 was granted and assigned to Metaproteomics on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Metaproteomics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7820206

Patent Inventor Names

Terrence Howell0

John G. Babish0

Matthew L. Tripp0

Robert Lerman0

Daniel O. Lukaczer0

DeAnn J. Liska0

Gary K. Darland0

Jeffrey S. Bland0

Date of Patent

October 26, 2010

Patent Application Number

11344554

Date Filed

January 30, 2006

Patent Primary Examiner

‌

Michael V Meller

Patent abstract

A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops.